This Dutch Startup's AI Agent Is Quietly Transforming Hearing Care

Jan de Vries · 2026-08-28

You know that feeling when a startup idea just clicks? It's not just about another app or a slick website. It's about solving a real, human problem in a way that feels almost obvious in hindsight. That's the story coming out of Maastricht, a city in the Netherlands, where a new venture called Clementine has just secured a significant seed round to do exactly that. They've raised $2 million. But the money is just fuel. The real story is what they're building with it. ### The Problem No One Wants to Talk About Let's talk about hearing loss for a second. It affects roughly 1.5 billion people globally. That's a staggering number. But here's the kicker: nearly 80% of those people never seek treatment. And for those who finally do? They typically wait over eight years. Eight years of gradual withdrawal, missed conversations, and quiet frustration. Why the wait? It's complicated. There's stigma. There's fear. There's the daunting process of calling a clinic, maybe getting put on hold, and having to explain your very personal struggle to a stranger. It's a massive emotional and practical barrier. Clementine's founder, Vince van de Weijer, saw this disconnect clearly. "Clinics don't need more leads," he says. "They need better conversations at the right moment." ### Meet Matthew: The AI Hearing Care Agent So, what's their solution? It's not a new hearing aid. It's a new front door. Clementine has built the world's first AI hearing activation platform, and at its heart is an AI agent named Matthew. Think of Matthew as a compassionate, infinitely patient guide. This isn't a cold chatbot. It's an agent built with behavioral science in mind, designed to engage prospective patients directly. Here's what it does: - Answers questions 24/7, with zero judgment and no waiting list - Educates users about hearing health in a low-pressure way - Gently helps people overcome those emotional barriers we talked about - Guides them toward the appropriate care when they're ready For a clinic, this is a game-changer. Matthew handles the initial, time-consuming conversations, turns inquiries into actual bookings, and frees up human staff for the complex, in-person care. It's about scaling compassion. ### Why Investors Are Betting on This Approach The $2 million seed round was led by Healthy.Capital, an Amsterdam-based investor focused on early-stage HealthTech. They've backed other promising names like Pharmi and OpenUp. Douwe Jippes, a managing partner at the firm, explained the bet: "Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally. We believe this approach will fundamentally change how people with hearing disability engage with healthcare." That last part is key. They're not just building software for clinics; they're aiming to change a global behavior pattern. That's the kind of impact that gets an investor's attention. The timing of this funding is also interesting. It comes right after Clementine expanded into North America through a partnership with Zoolstra, a marketing agency that works with hearing clinics across the United States and Canada. They're not thinking small. ### What's Next for Clementine? So, where does that $2 million go? The plan is twofold. First, they'll deepen the AI capabilities of Matthew, making those conversations even more natural and effective. Second, they'll expand their network. We're talking more partnerships with hearing clinics, sure, but also optical retailers and other healthcare organizations. The vision is to make Matthew a ubiquitous, trusted first step in the hearing care journey. It's a simple but powerful idea: meet people where they are, with empathy and technology, long before they walk into a clinic. By pairing AI with a deep understanding of human behavior, Clementine isn't just selling a tool. They're trying to shorten that eight-year wait, one conversation at a time. And honestly? That's a mission worth listening to.